Bonefačić, B., Bogović Crnčić, T., Ilić Tomaš, M., Girotto, N. & Grbac Ivanković, S. (2020). The significance of serum thyroglobulin
measurement before and after the treatment of
toxic nodular goiter with 131I. Nuclear Medicine Communications, 41. (4), 344-349. doi: 10.1097/mnm.0000000000001153
Bonefačić, Boris, et al. "The significance of serum thyroglobulin
measurement before and after the treatment of
toxic nodular goiter with 131I." Nuclear Medicine Communications, vol. 41, no. 4, 2020, pp. 344-349. https://doi.org/10.1097/mnm.0000000000001153
Bonefačić, Boris, Tatjana Bogović Crnčić, Maja Ilić Tomaš, Neva Girotto and Svjetlana Grbac Ivanković. "The significance of serum thyroglobulin
measurement before and after the treatment of
toxic nodular goiter with 131I." Nuclear Medicine Communications 41, no. 4 (2020): 344-349. https://doi.org/10.1097/mnm.0000000000001153
Bonefačić, B., et al. (2020) 'The significance of serum thyroglobulin
measurement before and after the treatment of
toxic nodular goiter with 131I', Nuclear Medicine Communications, 41(4), pp. 344-349. doi: 10.1097/mnm.0000000000001153
Bonefačić B, Bogović Crnčić T, Ilić Tomaš M, Girotto N, Grbac Ivanković S. The significance of serum thyroglobulin
measurement before and after the treatment of
toxic nodular goiter with 131I. Nuclear Medicine Communications [Internet]. 2020 [cited 2024 November 27];41(4):344-349. doi: 10.1097/mnm.0000000000001153
B. Bonefačić, T. Bogović Crnčić, M. Ilić Tomaš, N. Girotto and S. Grbac Ivanković, "The significance of serum thyroglobulin
measurement before and after the treatment of
toxic nodular goiter with 131I", Nuclear Medicine Communications, vol. 41, no. 4, pp. 344-349, 2020. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:184:596498. [Accessed: 27 November 2024]